Assessment of the Carcinogenic Potential of Pretomanid in Transgenic Tg.rasH2 Mice

Ambroso, JL; Dillberger, J; Bruning-Barry, R; Yang, T

Ambroso, JL (通讯作者),RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.

INTERNATIONAL JOURNAL OF TOXICOLOGY, 2022; 41 (5): 367

Abstract

Pretomanid is a nitroimidazooxazine antimycobacterial drug that was approved as part of a three-drug oral regimen, consisting of bedaquiline, pretoman......

Full Text Link